Literature DB >> 9549582

Stimulation of bone formation by intraosseous injection of basic fibroblast growth factor in ovariectomised rats.

K Nakamura1, T Kurokawa, I Aoyama, K Hanada, M Tamura, H Kawaguchi.   

Abstract

The effect on intraosseous bone formation of a single local injection of recombinant human basic fibroblast growth factor into trabecular bones was examined in ovariectomised osteoporotic rats. Fibroblast growth factor (400 micrograms), or the vehicle alone, was injected into the ilium at 16 weeks after ovariectomy or a simulated operation. Bone mineral density in the ovariectomised rats increased to a level similar to the latter at 2 weeks and reached a maximum at 8 weeks. After 8 weeks, BMD decreased slowly and the value at 24 weeks was still higher than that in the ovariectomised rats. Fibroblast growth factor stimulated osteoid formation in the first 2 weeks, bone volume reaching a peak at 8 weeks. From 8 to 12 weeks, bone resorption increased, resulting in decreases in bone volume to the levels of the group with simulated operations at 24 weeks. Structural analysis at 8 and 24 weeks showed that ovariectomy decreased the continuity of trabeculae and the injection of fibroblast growth factor restored it to levels higher than, or equal to, those who had the simulated operation. The present study demonstrated that intraosseous fibroblast growth factor given to ovariectomised rats restored bone volume and quality to the levels of the rats who had a simulated operation only.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9549582      PMCID: PMC3619651          DOI: 10.1007/s002640050207

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  7 in total

Review 1.  Role of fibroblast growth factor 2 and Wnt signaling in anabolic effects of parathyroid hormone on bone formation.

Authors:  Yurong Fei; Marja M Hurley
Journal:  J Cell Physiol       Date:  2012-11       Impact factor: 6.384

2.  Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation.

Authors:  A Montero; Y Okada; M Tomita; M Ito; H Tsurukami; T Nakamura; T Doetschman; J D Coffin; M M Hurley
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

3.  Fibroblast growth factor 2 stimulation of osteoblast differentiation and bone formation is mediated by modulation of the Wnt signaling pathway.

Authors:  Yurong Fei; Liping Xiao; Thomas Doetschman; Douglas J Coffin; Marja M Hurley
Journal:  J Biol Chem       Date:  2011-10-10       Impact factor: 5.157

4.  Basic fibroblast growth factor forms new trabeculae that physically connect with pre-existing trabeculae, and this new bone is maintained with an anti-resorptive agent and enhanced with an anabolic agent in an osteopenic rat model.

Authors:  N E Lane; J Kumer; W Yao; T Breunig; T Wronski; G Modin; J H Kinney
Journal:  Osteoporos Int       Date:  2003-05-24       Impact factor: 4.507

5.  In vitro and in vivo evidence for stimulation of bone resorption by an EP4 receptor agonist and basic fibroblast growth factor: Implications for their efficacy as bone anabolic agents.

Authors:  M E Downey; L S Holliday; J I Aguirre; T J Wronski
Journal:  Bone       Date:  2008-10-25       Impact factor: 4.398

6.  Fibroblast growth factor 2 positively regulates expression of activating transcription factor 4 in osteoblasts.

Authors:  Yurong Fei; Liping Xiao; Marja M Hurley
Journal:  Biochem Biophys Res Commun       Date:  2009-11-12       Impact factor: 3.575

7.  Opposing effects of Sca-1(+) cell-based systemic FGF2 gene transfer strategy on lumbar versus caudal vertebrae in the mouse.

Authors:  K-H W Lau; S-T Chen; X Wang; S Mohan; J E Wergedal; C Kesavan; A K Srivastava; D S Gridley; S L Hall
Journal:  Gene Ther       Date:  2016-03-02       Impact factor: 4.184

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.